Skip to main content

Table 3 Number of patients diagnosed with HBOC and received RRSO

From: Impact of lower co-payments on risk-reducing salpingo-oophorectomy and BRCA testing in Japan

 

Pre-coverage period

(6 years)

Post-coverage period

(1 year 9 months)

p*

Number of HBOC (mean)

24 (4/year)

18 (10/year)

 

Number of RRSO (mean)

7 (1/year)

11 (6/year)

 

Ratio of RRSO/HBOC

29.1%

61.1%

<0.05

  1. HBOC hereditary breast and ovarian cancer, RRSO risk-reducing salpingo-oophorectomy
  2. *Fisher's exact test